2022
DOI: 10.3389/fphar.2022.825948
|View full text |Cite
|
Sign up to set email alerts
|

Tracking TRYCAT: A Critical Appraisal of Kynurenine Pathway Quantifications in Blood

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
3
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
4
1

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(3 citation statements)
references
References 55 publications
0
3
0
Order By: Relevance
“…Furthermore, this study did not account for protein binding of the metabolites. Measurements of free metabolites and albumin levels would offer deeper insight into tryptophan metabolism and should be prioritized for future investigations [51,52].…”
Section: Limitationsmentioning
confidence: 99%
“…Furthermore, this study did not account for protein binding of the metabolites. Measurements of free metabolites and albumin levels would offer deeper insight into tryptophan metabolism and should be prioritized for future investigations [51,52].…”
Section: Limitationsmentioning
confidence: 99%
“…Hepatic and metabolic profiles, especially those associated with IR, are higher in PE than in healthy pregnant women [12]. One of the less studied pathways in the PE is the kynurenine pathway (KP), which degrades 95% of the tryptophan (TRP) to kynurenine (KYN) and either its neurotoxic or neuroprotective immunogenic metabolites [13]. KYN is converted to kynurenic acid (KYNA) by transamination to 3-hydroxykynurenine (3-HK) by hydroxylation.…”
Section: Introductionmentioning
confidence: 99%
“…Demonstrating this differentiating power may however prove to be challenging given that (1) different neuropsychiatric illnesses show substantial similarities in the alterations observed in these pathways and (2) these metabolites are also heavily vulnerably to lifestyle factors, as evidenced by modulating effects of BMI, glucose and lipid profiles and other metabolic markers, smoking habits and alimentation status; all of which are themselves affected in neuropsychiatric patients. 7 …”
mentioning
confidence: 99%